Informative
- Pharmaceutical
- Medical Device
FDA QSR (21 CFR Part 820)
User Account





Remember me

Lost your password?

HOME
BLOG
FDA 510(k)
The 510(k) Program: Evaluating Substantial Equivalence in Premarket Notifications [510(k)]

2019.02.18

The 510(k) Program: Evaluating Substantial Equivalence in Premarket Notifications [510(k)]

The 510(k) Program: Evaluating Substantial Equivalence in Premarket Notifications [510(k)]

]]>

Post
Share
Hatena
LINE
RSS
feedly
Pin it
note

Refuse to Accept Policy for 510(k)s Previous post レビュと承認について Next post

Related post

2019.02.18

Guidance for the Content of Premarket Submissions for Software Contained…

2019.01.13

FDA 510(k)申請審査の厳格化とS/Wの信頼性保証について

2019.02.18

Refuse to Accept Policy for 510(k)s

Comment

0 Comments
0 Trackbacks

There are no comment yet.

TRACKBACK URL

There are no trackback yet.

Click here to cancel reply.

NAME( required )

E-MAIL( required ) - will not be published -

URL

Category

Category

Recent post

2026.01.29

Understanding CFR: The Foundation of U.S. Regulatory Framework

2026.01.29

The Birth of 21 CFR Part 11: A Historical Perspective

2026.01.29

AI Learns 24/7/365

Banner1 Sub headline

Banner2 Sub headline

Sub headline

Sub headline

Sub headline

Description will be displayed here.Description will be displayed here.

Informative
- Pharmaceutical
- Medical Device
FDA QSR (21 CFR Part 820)
User Account

Informative
- Pharmaceutical
- Medical Device
FDA QSR (21 CFR Part 820)
User Account

Informative
- Pharmaceutical
- Medical Device
FDA QSR (21 CFR Part 820)
User Account

Copyright © 2023

 Login
 Wishlist

Informative
- Pharmaceutical
- Medical Device
FDA QSR (21 CFR Part 820)
User Account

Added to cart

Your Cart Is Empty

0

Check out our shop to see what's available

Cart Total: Total¥0

Your cart is empty. Shop now →

We noticed you're visiting from Japan. We've updated our prices to Japanese yen for your shopping convenience. Use United States (US) dollar instead. Dismiss